Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Navigation/Suche

• Forscher*innen.
• Institutionen.
• Projekte.
• Publikationen.
• Partner.
• Geldgeber.
• Ausstattung.
• Knowhow.
• Forschungsfelder.

Publikationen

Suchbegriffe: PROSTATIC NEOPLASMS - PATHOLOGY , . Treffer: 47

2019

Beer, L; Polanec, SH; Baltzer, PAT; Schatzl, G; Georg, D; Schestak, C; Dutschke, A; Herrmann, H; Mazal, P; Brendel, AK; Shariat, SF; Ringl, H; Helbich, TH; Apfaltrer, P 4D perfusion CT of prostate cancer for image-guided radiotherapy planning: A proof of concept study.
PLoS One. 2019; 14(12):e0225673-e0225673 Doi: 10.1371/journal.pone.0225673 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2017

Kaufmann, S; Mischinger, J; Amend, B; Rausch, S; Adam, M; Scharpf, M; Fend, F; Kramer, U; Notohamiprodjo, M; Nikolaou, K; Stenzl, A; Bedke, J; Kruck, S First report of robot-assisted transperineal fusion versus off-target biopsy in patients undergoing repeat prostate biopsy.
World J Urol. 2017; 35(7):1023-1029 Doi: 10.1007/s00345-016-1970-8
Web of Science PubMed FullText FullText_MUG

 

Renner, W; Langsenlehner, U; Krenn-Pilko, S; Eder, P; Langsenlehner, T BCL2 genotypes and prostate cancer survival.
Strahlenther Onkol. 2017; 193(6):466-471 Doi: 10.1007/s00066-017-1126-9 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2016

Rausch, S; Hennenlotter, J; Scharpf, M; Teepe, K; Kühs, U; Aufderklamm, S; Bier, S; Mischinger, J; Gakis, G; Stenzl, A; Schwentner, C; Todenhöfer, T Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma.
J Cancer Res Clin Oncol. 2016; 142(5):937-947 Doi: 10.1007/s00432-015-2107-y
Web of Science PubMed FullText FullText_MUG

 

Seles, M; Gutschi, T; Mayrhofer, K; Fischereder, K; Ehrlich, G; Gallé, G; Gutschi, S; Pachernegg, O; Pummer, K; Augustin, H Sampling of the anterior apical region results in increased cancer detection and upgrading in transrectal repeat saturation biopsy of the prostate.
BJU Int. 2016; 117(4):592-597 Doi: 10.1111/bju.13108 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2015

Augustin, H; Mayerhofer, K; Seles, M; Pummer, K Is There a Role for Active Surveillance in Low-Risk Prostate Cancer?
Urol Int. 2015; 95(2):125-131 Doi: 10.1159/000371895 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Belic, J; Koch, M; Ulz, P; Auer, M; Gerhalter, T; Mohan, S; Fischereder, K; Petru, E; Bauernhofer, T; Geigl, JB; Speicher, MR; Heitzer, E Rapid Identification of Plasma DNA Samples with Increased ctDNA Levels by a Modified FAST-SeqS Approach.
Clin Chem. 2015; 61(6):838-849 Doi: 10.1373/clinchem.2014.234286 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Lucca, I; Shariat, SF; Briganti, A; Lotan, Y; Roehrborn, CG; Montorsi, F; Remzi, M; Seitz, C; Fajkovic, H; Klingler, C; Karakiewicz, PI; Sun, M; Rouprêt, M; Loidl, W; Pummer, K; Klatte, T Validation of tertiary Gleason pattern 5 in Gleason score 7 prostate cancer as an independent predictor of biochemical recurrence and development of a prognostic model.
Urol Oncol. 2015; 33(2):71.e21-71.e26 Doi: 10.1016/j.urolonc.2014.08.011
Web of Science PubMed FullText FullText_MUG

 

Todenhöfer, T; Hennenlotter, J; Faber, F; Wallwiener, D; Schilling, D; Kühs, U; Aufderklamm, S; Bier, S; Mischinger, J; Gakis, G; Fehm, T; Stenzl, A; Schwentner, C Significance of apoptotic and non-apoptotic disseminated tumor cells in the bone marrow of patients with clinically localized prostate cancer.
Prostate. 2015; 75(6):637-645 Doi: 10.1002/pros.22947
Web of Science PubMed FullText FullText_MUG

 

2014

Kluth, LA; Abdollah, F; Xylinas, E; Rieken, M; Fajkovic, H; Sun, M; Karakiewicz, PI; Seitz, C; Schramek, P; Herman, MP; Becker, A; Loidl, W; Pummer, K; Nonis, A; Lee, RK; Lotan, Y; Scherr, DS; Seiler, D; Chun, FK; Graefen, M; Tewari, A; Gönen, M; Montorsi, F; Shariat, SF; Briganti, A Pathologic nodal staging scores in patients treated with radical prostatectomy: a postoperative decision tool.
Eur Urol. 2014; 66(3):439-446 Doi: 10.1016/j.eururo.2013.06.041
Web of Science PubMed FullText FullText_MUG

 

Ponholzer, A; Trubel, S; Schramek, P; Wimpissinger, F; Feichtinger, H; Springer, C; Wehrberger, C; Fischereder, K; Pummer, K; Martini, T; Mayr, R; Pycha, A; Madersbacher, S Prostate cancer at the peripheral end of prostate biopsy specimen predicts increased risk of positive resection margin after radical prostatectomy: results of a prospective multi-institutional study.
World J Urol. 2014; 32(4):911-916 Doi: 10.1007/s00345-014-1252-2
Web of Science PubMed FullText FullText_MUG

 

Pummer, K; Rieken, M; Augustin, H; Gutschi, T; Shariat, SF Innovations in diagnostic imaging of localized prostate cancer.
World J Urol. 2014; 32(4):881-890 Doi: 10.1007/s00345-013-1172-6
Web of Science PubMed FullText FullText_MUG

 

Thurner, EM; Krenn-Pilko, S; Langsenlehner, U; Renner, W; Gerger, A; Kapp, KS; Langsenlehner, T Association of genetic variants in apoptosis genes FAS and FASL with radiation-induced late toxicity after prostate cancer radiotherapy.
Strahlenther Onkol. 2014; 190(3):304-309 Doi: 10.1007/s00066-013-0485-0
Web of Science PubMed FullText FullText_MUG

 

Todenhöfer, T; Hennenlotter, J; Leidenberger, P; Wald, A; Hohneder, A; Kühs, U; Mischinger, J; Aufderklamm, S; Gakis, G; Blumenstock, G; Stenzl, A; Schwentner, C Serum receptor activator of nuclear factor κB ligand (RANKL) levels predict biochemical recurrence in patients undergoing radical prostatectomy.
BJU Int. 2014; 113(1):152-159 Doi: 10.1111/j.1464-410X.2012.11759.x
Web of Science PubMed FullText FullText_MUG

 

2013

Augustin, H; Mayrhofer, K; Pummer, K; Mannweiler, S Relationship between prostate cancer gene 3 (PCA3) and characteristics of tumor aggressiveness.
Prostate. 2013; 73(2):203-210 Doi: 10.1002/pros.22558
Web of Science PubMed FullText FullText_MUG

 

Egevad, L; Ahmad, AS; Algaba, F; Berney, DM; Boccon-Gibod, L; Compérat, E; Evans, AJ; Griffiths, D; Grobholz, R; Kristiansen, G; Langner, C; Lopez-Beltran, A; Montironi, R; Moss, S; Oliveira, P; Vainer, B; Varma, M; Camparo, P Standardization of Gleason grading among 337 European pathologists.
Histopathology. 2013; 62(2):247-256 Doi: 10.1111/his.12008
Web of Science PubMed FullText FullText_MUG

 

Langsenlehner, T; Döller, C; Winkler, P; Gallé, G; Kapp, KS Impact of inter- and intrafraction deviations and residual set-up errors on PTV margins. Different alignment techniques in 3D conformal prostate cancer radiotherapy.
Strahlenther Onkol. 2013; 189(4):321-328 Doi: 10.1007/s00066-012-0303-0
Web of Science PubMed FullText FullText_MUG

 

2012

Augustin, H; Auprich, M; Mannweiler, S; Pachernegg, O; Al-Ali, BM; Pummer, K Prostate cancers detected by saturation repeat biopsy impairs the Partin tables' accuracy to predict final pathological stage.
BJU Int. 2012; 110(3):363-368 Doi: 10.1111/j.1464-410X.2011.10765.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Auprich, M; Augustin, H; Budäus, L; Kluth, L; Mannweiler, S; Shariat, SF; Fisch, M; Graefen, M; Pummer, K; Chun, FK A comparative performance analysis of total prostate-specific antigen, percentage free prostate-specific antigen, prostate-specific antigen velocity and urinary prostate cancer gene 3 in the first, second and third repeat prostate biopsy.
BJU Int. 2012; 109(11):1627-1635 Doi: 10.1111/j.1464-410X.2011.10584.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Chromecki, TF; Cha, EK; Pummer, K; Scherr, DS; Tewari, AK; Sun, M; Fajkovic, H; Roehrborn, CG; Ashfaq, R; Karakiewicz, PI; Shariat, SF Prognostic value of insulin-like growth factor II mRNA binding protein 3 in patients treated with radical prostatectomy.
BJU Int. 2012; 110(1):63-68 Doi: 10.1111/j.1464-410X.2011.10703.x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Krones, E; Stauber, R; Vieth, M; Langner, C Hypertrophic gastric folds caused by metastatic prostate adenocarcinoma.
Endoscopy. 2012; 44 Suppl 2 UCTN(3):E47-E48 Doi: 10.1055/s-0031-1291524 (- Case Report) [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Todenhöfer, T; Hennenlotter, J; Feyerabend, S; Aufderklamm, S; Mischinger, J; Kühs, U; Gerber, V; Fetisch, J; Schilling, D; Hauch, S; Stenzl, A; Schwentner, C Preliminary experience on the use of the Adnatest® system for detection of circulating tumor cells in prostate cancer patients.
Anticancer Res. 2012; 32(8):3507-3513
Web of Science PubMed

 

Tötsch, M New developments in cytology.
Pathologe. 2012; 33(4):277-279 Doi: 10.1007/s00292-012-1572-1 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2011

Auprich, M; Chun, FK; Ward, JF; Pummer, K; Babaian, R; Augustin, H; Luger, F; Gutschi, S; Budäus, L; Fisch, M; Huland, H; Graefen, M; Haese, A Critical assessment of preoperative urinary prostate cancer antigen 3 on the accuracy of prostate cancer staging.
Eur Urol. 2011; 59(1):96-105 Doi: 10.1016/j.eururo.2010.10.024
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Egevad, L; Algaba, F; Berney, DM; Boccon-Gibod, L; Compérat, E; Evans, AJ; Grobholz, R; Kristiansen, G; Langner, C; Lockwood, G; Lopez-Beltran, A; Montironi, R; Oliveira, P; Schwenkglenks, M; Vainer, B; Varma, M; Verger, V; Camparo, P Interactive digital slides with heat maps: a novel method to improve the reproducibility of Gleason grading.
Virchows Arch. 2011; 459(2):175-182 Doi: 10.1007/s00428-011-1106-x [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG Google Scholar

 

Langsenlehner, T; Renner, W; Gerger, A; Hofmann, G; Thurner, EM; Kapp, KS; Langsenlehner, U Impact of VEGF gene polymorphisms and haplotypes on radiation-induced late toxicity in prostate cancer patients.
Strahlenther Onkol. 2011; 187(12):784-791 Doi: 10.1007/s00066-011-1106-4
Web of Science PubMed FullText FullText_MUG

 

Wibmer, C; Leithner, A; Hofmann, G; Clar, H; Kapitan, M; Berghold, A; Windhager, R Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems.
Spine (Phila Pa 1976). 2011; 36(23): 1977-1986. Doi: 10.1097/BRS.0b013e3182011f84
Web of Science PubMed FullText FullText_MUG

 

2010

Fuchsjager, MH; Pucar, D; Zelefsky, MJ; Zhang, ZG; Mo, QX; Ben-Porat, LS; Shukla-Dave, A; Wang, LA; Reuter, VE; Hricak, H PREDICTING POST-EXTERNAL BEAM RADIATION THERAPY PSA RELAPSE OF PROSTATE CANCER USING PRETREATMENT MRI
INT J RADIAT ONCOL. 2010; 78(3): 743-750. Doi: 10.1016/j.ijrobp.2009.08.040 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2009

Augustin, H; Fritz, GA; Ehammer, T; Auprich, M; Pummer, K Accuracy of 3-Tesla magnetic resonance imaging for the staging of prostate cancer in comparison to the Partin tables.
Acta Radiol. 2009; 50(5): 562-569. Doi: 10.1080/02841850902889846
Web of Science PubMed FullText FullText_MUG

 

Chun, FK; Suardi, N; Capitanio, U; Jeldres, C; Ahyai, S; Graefen, M; Haese, A; Steuber, T; Erbersdobler, A; Montorsi, F; Huland, H; Karakiewicz, PI Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
Eur Urol. 2009; 55(3):617-28-6 Doi: 10.1016/j.eururo.2008.04.099
Web of Science PubMed FullText FullText_MUG

 

Fuchsjäger, M; Akin, O; Shukla-Dave, A; Pucar, D; Hricak, H The role of MRI and MRSI in diagnosis, treatment selection, and post-treatment follow-up for prostate cancer.
Clin Adv Hematol Oncol. 2009; 7(3):193-202
PubMed Google Scholar

 

Galosi, AB; Montironi, R; Fabiani, A; Lacetera, V; Galle, G; Muzzonigro, G Cystic lesions of the prostate gland: an ultrasound classification with pathological correlation.
J UROL. 2009; 181(2): 647-657. Doi: 10.1016/j.juro.2008.10.006
Web of Science PubMed FullText FullText_MUG

 

Poutahidis, T; Rao, VP; Olipitz, W; Taylor, CL; Jackson, EA; Levkovich, T; Lee, CW; Fox, JG; Ge, ZM; Erdman, SE CD4+ lymphocytes modulate prostate cancer progression in mice.
Int J Cancer. 2009; 125(4):868-878 Doi: 10.1002/ijc.24452 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2008

Jeldres, C; Suardi, N; Saad, F; Montorsi, F; Shariat, SF; Perrotte, P; Bhojani, N; Walz, J; Hutterer, GC; Graefen, M; Valiquette, L; Karakiewicz, PI High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer.
Eur Urol. 2008; 54(1):97-105 Doi: 10.1016/j.eururo.2007.10.070
Web of Science PubMed FullText FullText_MUG

 

Kelly, K; Brader, P; Rein, A; Shah, JP; Wong, RJ; Fong, Y; Gil, Z Attenuated multimutated herpes simplex virus-1 effectively treats prostate carcinomas with neural invasion while preserving nerve function.
FASEB J. 2008; 22(6):1839-1848 Doi: 10.1096/fj.07-097808 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Langsenlehner, T; Langsenlehner, U; Renner, W; Kapp, KS; Krippl, P; Hofmann, G; Clar, H; Pummer, K; Mayer, R The Glu228Ala polymorphism in the ligand binding domain of death receptor 4 is associated with increased risk for prostate cancer metastases.
Prostate. 2008; 68(3):264-268 Doi: 10.1002/pros.20682
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2007

Chun, FK; Briganti, A; Graefen, M; Montorsi, F; Porter, C; Scattoni, V; Gallina, A; Walz, J; Haese, A; Steuber, T; Erbersdobler, A; Schlomm, T; Ahyai, SA; Currlin, E; Valiquette, L; Heinzer, H; Rigatti, P; Huland, H; Karakiewicz, PI Development and external validation of an extended 10-core biopsy nomogram.
Eur Urol. 2007; 52(2):436-44 Doi: 10.1016/j.eururo.2006.08.039
Web of Science PubMed FullText FullText_MUG

 

Zorn, KC; Gallina, A; Hutterer, GC; Walz, J; Shalhav, AL; Zagaja, GP; Valiquette, L; Gofrit, ON; Orvieto, MA; Taxy, JB; Karakiewicz, PI External validation of a nomogram for prediction of side-specific extracapsular extension at robotic radical prostatectomy.
J ENDOUROL. 2007; 21(11): 1345-1351. Doi: 10.1089/end.2007.0044
Web of Science PubMed FullText FullText_MUG

 

2006

Topakian, R; Stieglbauer, K; Rotaru, J; Haring, HP; Aichner, FT; Pichler, R Hypocalcemic choreoathetosis and tetany after bisphosphonate treatment.
Mov Disord. 2006; 21(11):2026-2027 Doi: 10.1002/mds.21094 (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2005

Steuber, T; Karakiewicz, PI; Augustin, H; Erbersdobler, A; Lange, I; Haese, A; Chun, KH; Walz, J; Graefen, M; Huland, H Transition zone cancers undermine the predictive accuracy of Partin table stage predictions.
J UROL. 2005; 173(3): 737-741. Doi: 10.1097/01.ju.0000152591.33259.f9
Web of Science PubMed FullText FullText_MUG

 

2004

Augustin, H; Eggert, T; Wenske, S; Karakiewicz, PI; Palisaar, J; Daghofer, F; Huland, H; Graefen, M Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer.
J UROL. 2004; 171(1): 177-181. Doi: 10.1097/01.ju.0000099827.77355.a7
Web of Science PubMed FullText FullText_MUG

 

2002

Schips, L; Zigeuner, RE; Langner, C; Mayer, R; Pummer, K; Hubmer, G Metastasis of an ascending colon carcinoma in the prostate 10 years after hemicolectomy.
J Urol. 2002; 168(2):641-642 Doi: 10.1097%2F00005392-200208000-00055 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

2000

Djavan, B; Zlotta, A; Remzi, M; Ghawidel, K; Basharkhah, A; Schulman, CC; Marberger, M Optimal predictors of prostate cancer on repeat prostate biopsy: a prospective study of 1,051 men.
J Urol. 2000; 163(4):1144-1148 Doi: 10.1016/S0022-5347(05)67711-7
Web of Science PubMed FullText FullText_MUG

 

1999

Djavan, B; Susani, M; Bursa, B; Basharkhah, A; Simak, R; Marberger, M Predictability and significance of multifocal prostate cancer in the radical prostatectomy specimen.
Tech Urol. 1999; 5(3):139-142
PubMed

 

1994

Thalhammer, F; Gisslinger, H; Chott, A; Haas, O; Etele-Hainz, A; Helbich, T; Kusec, R; Linkesch, W; Simonitsch, I; Strobl, H Granulocytic sarcoma of the prostate as the first manifestation of a late relapse of acute myelogenous leukemia.
Ann Hematol. 1994; 68(2):97-99 Doi: 10.1007/BF01715141 (- Case Report)
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1992

Rao, S; Badani, K; Schildhauer, T; Borges, M Metastatic malignancy of the cervical spine. A nonoperative history.
Spine (Phila Pa 1976). 1992; 17(10 Suppl): S407-S412. Doi: 10.1097/00007632-199210001-00011
Web of Science PubMed FullText FullText_MUG Google Scholar

 

1989

Schoel, J; Smolle, J; Kerl, H Skin metastases in prostatic cancer. Immunohistologic indications of the primary tumor
HAUTARZT. 1989; 40(1): 34-36. (- Case Report)
Web of Science PubMed

 

↑ Seitenanfang / Navigation

© Med Uni Graz • Impressum